Xbrane Biopharma’s Shares Offering

Baker McKenzie advised Xbrane Biopharma on the deal.Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price of…

This content is for Standard 1 Year members only.
Login Join Now
Maha Kanaan

Author: Maha Kanaan

This content is for Standard 1 Year members only.
Login Join Now